Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2000
02/17/2000WO2000007427A2 Method for selective and optionally reversible degeneration of somatic plant tissue
02/17/2000WO2000001815A3 Neurotrophic factors
02/17/2000WO1999064583A3 Compositions and methods for modulating proteolytic degradation of intracellular targets
02/17/2000WO1999064451A3 Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof
02/17/2000WO1999062932A3 INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES
02/17/2000WO1999062534B1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
02/17/2000WO1999061624A3 Polyhydroxyalkanoate biopolymer compositions
02/17/2000WO1999061613A3 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
02/17/2000WO1999061601A3 Aav5 vector and uses thereof
02/17/2000WO1999060110A9 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
02/17/2000WO1999058691A3 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
02/17/2000WO1999058675A3 Human genes and gene expression products v
02/17/2000WO1999057321A9 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
02/17/2000WO1999057241A9 Myelin basic protein peptides and uses thereof
02/17/2000WO1999056784A3 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
02/17/2000WO1999055859A3 Cd40-interacting and traf-interacting proteins
02/17/2000WO1999054466A3 Colon cancer-associated antigens and their diagnostic and therapeutic uses
02/17/2000WO1999053036A9 Ste20-related protein kinases
02/17/2000WO1999051779A9 Glaucoma therapeutics and diagnostics
02/17/2000WO1999051756A9 Promoter and constructions for expression of recombinant proteins in filamentous fungi
02/17/2000WO1999050461A9 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
02/17/2000WO1999047180A9 Chimeric adenoviral vectors for targeted gene delivery
02/17/2000WO1999046371A9 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery
02/17/2000WO1999032663A3 High throughput assay system
02/17/2000WO1998045456A8 2-deoxyglucose-6-phosphate (2-dog-6-p) phosphatase dna sequences as selection markers in plants
02/17/2000DE19938479A1 Test strips for DNA analysis have rows of different and spaced specific bonding agents to be scanned when treated with substances with fluorescent markers for analysis of the fluorescent emissions
02/17/2000DE19834909A1 Faserproteine und ihre Herstellung Fibrous proteins and their preparation
02/17/2000CA2672025A1 Genes involved in tolerance to environmental stress
02/17/2000CA2362013A1 Transgenic plant expressing soybean glycinin
02/17/2000CA2348151A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
02/17/2000CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
02/17/2000CA2346123A1 Recombinant poliovirus for the treatment of cancer
02/17/2000CA2342078A1 New salicylic acid inducible genes and promoters from tobacco
02/17/2000CA2339891A1 Chp polypeptide, a ligand of pak65
02/17/2000CA2339876A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes
02/17/2000CA2339734A1 Gel microdrops in genetic analysis
02/17/2000CA2339578A1 Novel genetic materials for transmission into maize
02/17/2000CA2339519A1 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants
02/17/2000CA2339416A1 Short oligonucleotides for the inhibition of vegf expression
02/17/2000CA2339413A1 Method for treatment of invasive cells
02/17/2000CA2339408A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom
02/17/2000CA2339365A1 Biodegradable high oxidative stability oils
02/17/2000CA2339352A1 N-acetylglycosaminyltransferase genes
02/17/2000CA2339348A1 Oligomers which inhibit expression of collagen genes
02/17/2000CA2339347A1 Novel g protein-coupled receptor cdna sequence
02/17/2000CA2339340A1 Antisense oligonucleotides for the inhibition of vegf expression
02/17/2000CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000CA2339178A1 2'-o-aminoethyloxyethyl-modified oligonucleotides
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2339084A1 Plant fatty acid desaturase promoters
02/17/2000CA2339083A1 Nucleic sequences coding for an at2 interacting protein interacting with the at2 receptor and their applications
02/17/2000CA2338983A1 Prevention and treatment of viral disease
02/17/2000CA2338385A1 Human receptor-associated proteins
02/17/2000CA2338383A1 Method for selective and optionally reversible degeneration of somatic plant tissue
02/17/2000CA2338382A1 Herpesviral vectors for gene delivery
02/17/2000CA2338187A1 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications
02/17/2000CA2338185A1 Thermostable in vitro complex with polymerase activity
02/17/2000CA2338020A1 Trimer of hiv env gene expression product
02/17/2000CA2338003A1 Nucleic acid module coding for alpha-glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
02/17/2000CA2338002A1 Plants synthesizing a modified starch, process for the generation of the plants, their use, and the modified starch
02/17/2000CA2337984A1 Plants, seeds and oils having an elevated total monounsaturated fatty acid content
02/17/2000CA2337980A1 Method to alter the fatty acid metabolism in plants
02/17/2000CA2337968A1 Herpesvirus preparations and their uses
02/17/2000CA2337963A1 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer
02/17/2000CA2337904A1 Novel genes in control of hematopoiesis
02/17/2000CA2337861A1 A plant disease resistance signalling gene: materials and methods relating thereto
02/17/2000CA2337741A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000CA2337694A1 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof
02/17/2000CA2337693A1 Transgenic animals having a modified glycoprotein v gene
02/17/2000CA2336592A1 Cell lines for the propagation of mutated herpes viruses
02/17/2000CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof
02/17/2000CA2336064A1 Fibrous proteins and the production thereof
02/17/2000CA2335648A1 A novel g protein-coupled receptor protein and its dna
02/17/2000CA2335344A1 Production and use of modified cystatins
02/17/2000CA2328494A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease
02/17/2000CA2305784A1 Mutated barnase gene and plant transformed by the same
02/17/2000CA2305680A1 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000CA2305308A1 Human cdnas encoding polypeptides having kinase functions
02/16/2000EP0979878A2 Method for detecting oligonucleotides and determining base sequence of nucleic acids
02/16/2000EP0979876A2 Method for producing fermentative product and stress-resistant microorganism
02/16/2000EP0979875A1 Plasmid derived from gluconobacter bacteria and vector
02/16/2000EP0979874A2 Protein and DNA sequence for pinosylvine-3-O-methyltransferase (PMT)
02/16/2000EP0979873A1 Gene for petunia transcription factor PetSPL2 and its use
02/16/2000EP0979872A1 Animal model for the development and therapy of diabetes mellitus
02/16/2000EP0979871A1 NOVEL dlg FAMILY MOLECULE, POLYNUCLEOTIDE ENCODING THE SAME, ANTIBODY AGAINST THE SAME, AND METHOD FOR DETECTING dlg GENE
02/16/2000EP0979870A1 Human Wnt-6 polypeptide
02/16/2000EP0979869A1 Short oligonucleotides for the inhibition of VEGF expression
02/16/2000EP0979868A2 Electrophoretic separation of nucleic acids from proteins at low pH
02/16/2000EP0979867A2 Immunodominant human T-cell epitopes of hepatitis C virus
02/16/2000EP0979831A2 Antibacterial peptides and antibacterial agents containing such peptides as an effective ingredient
02/16/2000EP0979410A1 Method for determining cytokine receptor activation by the use of an antibody
02/16/2000EP0979311A1 $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES
02/16/2000EP0979309A1 Oligonucleotides for enhanced bioavailability
02/16/2000EP0979308A1 Method of preparing a standard diagnostic gene transcript pattern
02/16/2000EP0979306A1 An assay for the measurement of dna synthesis rates
02/16/2000EP0979305A1 Mass label linked hybridisation probes
02/16/2000EP0979299A1 Bioluminescent reporter bacterium and methods for toxicity monitoring in biological wastewater treatment systems
02/16/2000EP0979298A1 Metastasis models using green fluorescent protein (gfp) as a marker
02/16/2000EP0979297A1 A conditional replication and expression system
02/16/2000EP0979296A2 Plant amino acid biosynthetic enzymes
1 ... 3284 3285 3286 3287 3288 3289 3290 3291 3292 3293 3294 3295 3296 3297 3298 3299 3300 3301 3302 3303 3304 ... 4023